Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or ...

The U.S. FDA has granted Fast Track designation for mRNA-4359 in combination with pembrolizumab for the treatment of ...
AOL

FDA refuses to review Moderna’s application for mRNA flu vaccine, company says

The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...

Moderna: The Case For Staying On The Sidelines

FDA reversal, patent relief, and mRESVIA risks show a commoditized market and lofty $20B valuation. See more here.

mRNA is poised to rise beyond infectious diseases, if it’s not derailed by R&D cuts

Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.
Hosted on MSN

Moderna faces lawsuit from BioNTech over next-generation COVID-19 shot

BioNTech SE BNTX has filed a patent infringement lawsuit against Moderna Inc. MRNA, alleging that Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, relies on proprietary technology developed and ...
WDSU

Moderna says FDA refuses its application for new mRNA flu vaccine

The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.The news is the ...
Monthly Prescribing Reference

Moderna’s mRNA Flu Vaccine Back Under FDA Review

If approved, this would be the first flu vaccine to use the same messenger RNA technology that powered Moderna’s COVID-19 shots. HealthDay News — In a sudden reversal, the US Food and Drug ...